Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/1991
03/19/1991US5001123 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
03/19/1991US5001122 Use of diazepinones for treating disorders of the microcirculation
03/19/1991CA2023763A1 Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method
03/19/1991CA1281651C Water soluble polyvinyl lactam-drug complexes
03/17/1991WO1991004252A1 New esters of thienyl carboxylic acids and amino alcohols, their quaternization products, and manufacture and use of said compounds
03/17/1991CA2025358A1 Treatment
03/16/1991WO1991004250A1 2-substituted-1(4)-aryl piperazines and the process for their preparation
03/16/1991WO1991004046A1 Gamma glutamyl transferases for treating diseases
03/16/1991WO1991004022A1 Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
03/16/1991CA2067156A1 2-substituted-1(4)-aryl piperazines and the process for their preparation
03/16/1991CA2065157A1 Gamma glutamyl transferases for treating diseases
03/16/1991CA2024283A1 3,4,5,6-tetrahydro-2h 1,7,4-benzodioxazonines as cardiovascular agents
03/16/1991CA2023936A1 Diol sulfonamide and sulfinyl renin inhibitors
03/14/1991CA2025084A1 Heteroaryl substituted imidazo [4,5-c] pyridines
03/13/1991EP0416740A2 Novel compounds with renin-inhibiting activity
03/13/1991EP0416678A1 Topical compositions containing Defibrotide
03/13/1991EP0416677A1 Compositions for topical cosmetic use containing depolymerized nucleic acids
03/13/1991EP0416609A2 Benzo[b]thiophene-containing lipoxygenase-inhibiting compounds
03/13/1991EP0416604A2 PAF-antagonists for the preparation of a medicament, useful for the treatment of heart diseases, caused by diminished beta-receptor-stimulation
03/13/1991EP0416581A1 Substituted N-benzylpiperidine amides
03/13/1991EP0416521A1 N-Benzyltropaneamides
03/13/1991EP0416520A1 Tricyclic quinolizine amides
03/13/1991EP0416499A2 Benzoylguanidines, process for their preparation, their use as medicaments as well as medicament containing them
03/13/1991EP0416479A1 1,5-Benzothiazepine derivatives and preparation thereof
03/13/1991EP0416393A1 Peptidyl difluorodiol renin inhibitors
03/13/1991EP0416383A2 Substituted aminopyridines
03/13/1991EP0416373A2 Amino acid derivatives
03/13/1991EP0416064A1 20-alkyl-13,14,18,18,19,19-hexadehydro-3-oxa-isocarbacycline derivatives and their pharmaceutical use
03/13/1991EP0415948A1 PROCESS FOR PREPARING A SUBSTITUTED OR AN UNSUBSTITUTED 4(5)-($g(v)-AMINOALKYL)IMIDAZOLE
03/13/1991EP0233291B1 2-arylbenzothiazine derivatives
03/13/1991CA2025093A1 Amino acid derivatives with renin-inhibiting properties, a process for the preparation thereof, agents containing these, and the use thereof
03/12/1991US4999372 New aminochromanol compounds
03/12/1991US4999371 Substituted 3,4-dihydro-2H-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds
03/12/1991US4999363 Tricyclic compounds
03/12/1991US4999361 Cardiovascular disorders, blood vessel relaxants
03/12/1991US4999345 Sulfonamide derivatives and drugs obtained therefrom
03/12/1991CA2025006A1 Condensed diazepinones, processes for their preparation and medicaments containing these compounds
03/12/1991CA2025005A1 Condensed diazepinones, process for preparing them and pharmaceutical compositions containing these compounds
03/12/1991CA2024661A1 Peptidase and isomerase inhibitors
03/12/1991CA1281334C Indole derivatives
03/12/1991CA1281330C2 Intermediates for the preparation of n-alkylated dipeptides and their esters
03/12/1991CA1281329C Lipoxygenase inhibitors
03/12/1991CA1281325C Benzofuran derivatives
03/12/1991CA1281324C Lipid derivatives, their production and use
03/08/1991CA2024630A1 Paf-antagonists for the preparation of a pharmaceutical composition suitable for treating heart diseases caused by reduced stimulation of .beta.-receptors
03/08/1991CA2021874A1 Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility
03/07/1991WO1991003099A1 Compressed powder medicaments
03/07/1991CA2024576A1 Hmg-coa reductase-inhibiting substituted amino-pyridines
03/06/1991EP0415886A2 Aza compounds
03/06/1991EP0415850A1 Bivalent metal salts of 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophene-acid, process for their preparation and pharmaceutical compositions containing them
03/06/1991EP0415776A2 Indolobenzoquinoline derivatives, their preparation and their use as anti-arrhythmic drugs
03/06/1991EP0415456A2 Xanthine compounds
03/06/1991EP0415413A1 Acat inhibitors
03/06/1991EP0415384A2 Heterogeneous synthesis of azepinones from esters
03/06/1991EP0415327A1 Vasodilating agent
03/06/1991EP0415219A1 ANF-Antagonist
03/06/1991EP0415065A1 Chroman derivatives
03/06/1991EP0415030A2 1-Substituted-1,2-dihydro-4-[(substituted)-phenyl]imidazo-[1,5-A]pyrimidine-8-carbonitriles
03/06/1991EP0414931A1 Hypotensive agent
03/06/1991EP0414895A1 OROTATE OF $g(a)-AMINO-$g(b)-PHENYL-BUTYRIC ACID
03/06/1991EP0414815A1 Blood substitute
03/06/1991CA2024698A1 Peptidyl diflurodiol renin inhibitors
03/06/1991CA2024581A1 Substituted n-benzylpiperidine amides
03/06/1991CA2024580A1 Tricyclic quinolizine amides
03/06/1991CA2024579A1 N-benzyltropaneamides
03/05/1991US4997846 Smooth muscle relaxants, hypotensives
03/05/1991US4997844 Compounds for the treatment of allergic or inflammatory diseases or shock conditions
03/05/1991US4997841 Indole derivatives
03/05/1991US4997840 Quinolone sulphonates having antihypertensive activity
03/05/1991US4997833 Aryloxy-aminoalkanes, and antihypertensive use thereof
03/05/1991US4997658 Method for enhancing the lowering of plasma cholesterol levels
03/05/1991CA2023099A1 Amino acid derivatives
03/02/1991CA2024053A1 Anf-antagonist
03/01/1991CA2024300A1 Acat inhibitors
03/01/1991CA2024252A1 Indolobenzoquinoline derivatives, their preparation and their use as anti-arrythmic drugs
03/01/1991CA2024137A1 Aza compounds
03/01/1991CA2024113A1 Substituted pyrimidinones as angiotensin ii antagonists
03/01/1991CA2024011A1 1-substituted-1,2-dihydro-4-[(substituted)-phenyl]imidazo-[ 1,5-a]pyrimidine-8-carbonitriles
03/01/1991CA2023790A1 1,5-benzothiazepine derivatives and preparation thereof
03/01/1991CA2023435A1 Non-digoxin-like na+, k+-atpase inhibitory factor
02/1991
02/28/1991DE3928287A1 Verwendung des (+)-enantiomeren von anipamil Use of (+) - enantiomer of anipamil
02/27/1991WO1991002524A1 Use of the (+)-enantiomer of anipamil
02/27/1991EP0414421A2 1-Oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
02/27/1991EP0414206A2 2,4,6-Substituted phenol derivatives
02/27/1991EP0414190A2 Phosphonate substituted amino or imino acids useful as antihypertensives
02/27/1991EP0414018A2 Process for the preparation of dehydrocycloclausenamide and its derivatives in the racemic form and as optically active (+)- or (-)-enantiomers
02/27/1991EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
02/27/1991EP0413750A1 Renin inhibitory peptides containing a substituted phenoxyacetyle group
02/27/1991EP0413694A1 Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker.
02/27/1991CN1049499A 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)- derivatives with properties of mucus-adjustment and antiischemia
02/27/1991CN1049455A Pharmaceutical dosage form improving bioavailability
02/27/1991CA2058287A1 Use of the (+) enantiomer of anipamil
02/26/1991US4996318 Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke
02/26/1991US4996233 Method of reducing porphyrin toxicity using fatty acids
02/26/1991US4996218 Chloroaniline derivatives
02/26/1991US4996215 Piperidine derivative and pharmaceutical composition containing the same
02/26/1991US4996213 Derivatives of 4-amino 3-carboxy naphthyridines and their pharmaceutical compositions
02/26/1991US4996211 Anticonvulsants, treating neurodegenerative diseases
02/26/1991US4996203 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
02/26/1991US4996159 Purified polypeptides